Cellectis (CLLS) Accounts Payables (2014 - 2026)
Cellectis (CLLS) recorded quarterly Accounts Payables of $17.1 million in Q1 2026, down 1.08% quarter-over-quarter from $17.3 million in Q4 2025, and down 0.69% on a YoY basis from $17.2 million in Q1 2025.
Cellectis (CLLS) Accounts Payables (2014 - 2026) Analysis & Trends
Cellectis' Accounts Payables history runs 13 years deep, the most recent figure standing at $17.1 million for Q1 2026.
- In Q1 2026, Accounts Payables fell 0.69% year-over-year to $17.1 million; the TTM figure through Mar 2026 stood at $17.1 million (down 0.69% YoY), while the FY2025 annual figure was $17.3 million, down 7.43% from the prior year.
- Accounts Payables was $17.1 million for Q1 2026 at Cellectis, down from $17.3 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $24.2 million in Q2 2022 to a low of -$145000.0 in Q1 2022.
- Historically, Accounts Payables has averaged $18.0 million across 5 years, with a median of $18.5 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables tumbled 100.59% in 2022, then jumped 15495.86% in 2023.
- A 5-year view of Accounts Payables shows it stood at $21.5 million in 2022, then decreased by 11.13% to $19.1 million in 2023, then declined by 2.12% to $18.7 million in 2024, then dropped by 7.43% to $17.3 million in 2025, then slipped by 1.08% to $17.1 million in 2026.
- The last three Accounts Payables figures came in at $17.1 million (Q1 2026), $17.3 million (Q4 2025), and $16.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | 17.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.09 Mn |
| Dec 31, 2025 | 17.28 Mn |
| Sep 30, 2025 | 16.10 Mn |
| Jun 30, 2025 | 17.52 Mn |
| Mar 31, 2025 | 17.21 Mn |
| Dec 31, 2024 | 18.66 Mn |
| Sep 30, 2024 | 18.51 Mn |
| Jun 30, 2024 | 18.21 Mn |
| Mar 31, 2024 | 16.05 Mn |
| Dec 31, 2023 | 19.07 Mn |
| Sep 30, 2023 | 20.48 Mn |
| Jun 30, 2023 | 19.23 Mn |
| Mar 31, 2023 | 22.32 Mn |
| Dec 31, 2022 | 21.46 Mn |
| Sep 30, 2022 | 22.35 Mn |
| Jun 30, 2022 | 24.16 Mn |
| Mar 31, 2022 | -145,000.00 |
| Dec 31, 2021 | 23.76 Mn |
| Sep 30, 2021 | 22.81 Mn |
| Jun 30, 2021 | 28.25 Mn |